Wednesday, October 21, 2009

DCGI to notify guidelines attached to Spurious Drugs Act to curb harassment of drug units

In a bid to curb the possible misuse of powers by drug inspectors under the newly amended Drugs & Cosmetics Act, the Drug Controller General of India has started initiatives to notify the guidelines attached to the Bill to avoid unnecessary harassment to genuine drug manufacturers by the drug inspectors.

The details can be read here.

No comments: